Advertisements



Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Launches Minastrin Generic In The United States

Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has unveiled the authorized generic version of Minastrin, an oral contraceptive that is c.....»»

Category: topSource: insidermonkeyMar 20th, 2017

Teva (TEVA) Launches Glumetza Generic, Inks Deal with Otsuka

Teva Pharmaceutical Industries Ltd. (TEVA) announced the launch of a generic version of Valeant Pharmaceuticals International, Inc.'s (VRX) diabetes drug, Glumetza, in the U.S. Teva .....»»

Category: topSource: zacksMay 16th, 2017

Teva Launches Authorized Generic of Allergan"s Minastrin

Teva Pharmaceutical I.....»»

Category: topSource: zacksMar 17th, 2017

Teva"s Stock Inches Higher Amid Cost-Cutting Plan

Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA), the troubled Israel-based generic and specialty medicines developer, confirmed with Bloomberg a plan to lower expenses and better manage its debt. read more.....»»

Category: blogSource: benzingaMar 23rd, 2017

The world’s biggest generic drugs producer is cutting 6,000 jobs: report

Teva Pharmaceutical Industries Ltd. plans to cut as many as 6,000 jobs, or about 11 percent of its global workforce.....»»

Category: topSource: moneycentralMar 23rd, 2017

Teva Pharmaceutical Industries Ltd (ADR) (TEVA), Mylan N.V. (MYL) Accused Of Price Fixing By 20 More States

The number of states accusing Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) and Mylan N.V. (NASDAQ:MYL) for price collusion have rise.....»»

Category: topSource: insidermonkeyMar 2nd, 2017

Manufacturing Delay Of Generic Drug From Pfizer Inc. (PFE) A Relief For Teva Pharmaceutical Industries Ltd (ADR) (TEVA)

Pfizer Inc. (NYSE:PFE) has been slapped with a warning letter by the Food and Drug Administration in regards to one of its fill/finish fac.....»»

Category: topSource: insidermonkeyFeb 22nd, 2017

Teva Pharmaceutical Industries Ltd. Reports Q4 Improvement Thanks to Actavis Deal

The generic and specialty drugmaker posts higher revenue in Q4 because of growth from a key acquisition......»»

Category: topSource: foxnewsFeb 13th, 2017

Teva CEO exits in ongoing crisis of confidence at drugmaker

Teva Pharmaceutical Industries was left without a permanent chief executive on Tuesday after Erez Vigodman stepped down, leaving new management to restore confidence in the world's biggest generic drugmaker after a series of missteps......»»

Category: topSource: foxnewsFeb 7th, 2017

Teva CEO exits amid crisis of confidence at drugmaker

TEL AVIV (Reuters) - The chief executive of Teva Pharmaceutical Industries has stepped down, leaving new management to overhaul the world's biggest maker of generic drugs and restore confidence after a series of missteps sent its shares plummeting......»»

Category: topSource: reutersFeb 7th, 2017

Teva, CEO part ways

Erez Vigodman has stepped down as president and CEO of Teva Pharmaceutical Industries Ltd. and left the generic drug company's board of directors. Teva (NYSE: TEVA) described the departure as a mutual agreement between the board and Vigodman. The chan.....»»

Category: topSource: bizjournalsFeb 7th, 2017

The CEO of generic drugmaker Teva just stepped down (TEVA)

Thomson ReutersFeb 6 (Reuters) - Israel-based generic drugmaker Teva Pharmaceutical Industries Ltd said on Monday that Chief Executive Erez Vigodman was stepping down effective immediately and would be replaced on an interim basis by Yitzhak.....»»

Category: topSource: businessinsiderFeb 6th, 2017

Teva CEO Erez Vigodman Steps Down

He's been CEO of the company since 2014. Israel-based generic drugmaker Teva Pharmaceutical Industries said on Monday that Chief Executive Erez Vigodman was stepping down effective immediately and would be replaced on an int.....»»

Category: europeSource: fortuneFeb 6th, 2017

Why United Parcel Service, Inc. (UPS), Teva Pharmaceutical Industries Ltd (ADR) (TEVA) and Under Armour Inc (UAA) Are 3 of Today’s Worst Stocks

InvestorPlaceInvestorPlace - Stock Market News, Stock Advice & Trading Tips Under Armour (UAA), Teva Pharmaceutical Industries (TEV.....»»

Category: topSource: investorplaceJan 31st, 2017

Court invalidates 4 Teva patents for MS drug

The U.S. District Court in Delaware ruled four of Teva Pharmaceutical Industries Ltd.'s patents for Copaxone were invalid, dealing Teva its latest setback in the company's efforts to ward off generic competition for its top revenue-producing product. T.....»»

Category: topSource: bizjournalsJan 31st, 2017

SEC, DOJ fine Teva Pharmaceutical $519 million to settle foreign bribery charges

The Securities and Exchange Commission and the Department of Justice jointly fined Teva Pharmaceutical Industries Limited , the largest generic drug manufacturer in the world, $519 milli.....»»

Category: topSource: marketwatchDec 22nd, 2016

20 States Accuse Generic Drug Companies of Price Fixing - New York Times

New York Times20 States Accuse Generic Drug Companies of Price FixingNew York TimesA Teva pharmaceutical factory in Godollo, Hungary. Teva, the world's largest generic-drug maker, is among the six companies accused of price fixing. Credit Akos Stiller.....»»

Category: topSource: googlenewsDec 15th, 2016

Teva Shares Slide on Management Change

Teva Pharmaceutical Industries shares sank on Tuesday after the company announced the appointment of Dipankar Bhattacharjee as chief executive for its global generic medicines group......»»

Category: blogSource: 247wallstDec 6th, 2016

Why Teva is Tanking

Shares of Teva Pharmaceutical Industries (TEVA) are tumbling today after the generic drug maker beat third-quarter earnings forecasts but offered lukewarm guidance. Credit Suisse analysts Vamil Divan and Muriel Chen contend that despite "low expectations.....»»

Category: blogSource: barronsNov 15th, 2016

Merrimack Pharmaceuticals Inc (MACK) Sees Earnings Boost As FDA Accepts Application For Generic Drug

Merrimack Pharmaceuticals Inc (NASDAQ:MACK) and Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) have moved closer to introducing their generic version of Johnson & Johnson (NYSE:JNJ) drug DOXIL to the market. The FDA has accepted an application from .....»»

Category: topSource: insidermonkeyNov 1st, 2016

Mylan: ‘Ouch, That Hurt’

That's how Guggenheim analyst Louise Chen and team describe the potential impact on Mylan (MYL) due to generic EpiPen products from companies like Teva Pharmaceutical Industries (TEVA) and Impax Laboratories (IPXL). They explain why:.....»»

Category: blogSource: barronsOct 19th, 2016